Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘IBD’

February 10th, 2017

FDA Approves Biosimilar to Humira

By Kanaaz Pereira kanaazpe

The FDA recently approved a biosimilar (trade name, Amjevita) to Humira (adalimumab). A biosimilar is a biological product that is highly similar to the originator drug, and has no clinical differences in terms of safety and effectiveness. Dr. Edward Loftus , M.D., talks about the potential of this drug to offer patients with chronic inflammatory diseases such as Crohn’s and ulcerative colitis an […]

View full entry

Tags: Amjevita, biosimilar, Crohn's disease, Edward Loftus, FDA, Humira, IBD, ulcerative colitis


May 11th, 2016

CCFA to Study Impact of Specific Diets on Crohn’s Disease

By Kanaaz Pereira kanaazpe

One of the first questions that people diagnosed with inflammatory bowel disease (IBD) have is, “What can I eat, and will changing my diet help with the symptoms or even cure my disease?”  The Crohn’s & Colitis Foundation of America (CCFA) has been given $2.5 million to investigate the value of a carbohydrate-rich diet and a Mediterranean-style diet in preventing relapse in […]

View full entry

Tags: Crohn's & Colitis Foundation of America (CCFA), dietary changes, Food and Crohn's Exacerbation Study (FACES), IBD, Sunanda Kane


May 6th, 2016

FDA Approves of Biosimilar to Infliximab

By Kanaaz Pereira kanaazpe

The FDA recently approved of a biosimilar (CT-P13) to infliximab, which is used for treating IBD patients, as well as patients suffering from rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The new drug would be the first biosimilar monoclonal antibody approved in the United States. Dr. Edward Loftus, M.D., explains how biosimilars work, and discusses […]

View full entry

Tags: biosimilar, CT-P13, Edward Loftus, FDA, IBD, infliximab, rheumatoid arthritis


May 6th, 2016

Can Oral Contraceptives Worsen Crohn’s Disease?

By Kanaaz Pereira kanaazpe

A new study, published in Gastroenterology, suggests that long-term use of combination oral contraceptives may increase the risk for surgery among women with established Crohn’s disease. The research team evaluated the association between oral contraceptives and risk for Crohn’s disease complications, including need for surgery and steroid use. They found that steroid use did not […]

View full entry

Tags: Crohn's disease, Gastroenterology, IBD, oral contraceptives, Sunanda Kane, surgery


May 3rd, 2016

Vedolizumab Safe for Inflammatory Bowel Disease

By Kanaaz Pereira kanaazpe

Vedolizumab (proposed trade name Entyvio), was developed as a treatment for patients with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD), who have failed at least one conventional therapy, including tumor necrosis factor (TNF) antagonists. Dr. Edward Loftus, M.D., reviews a recent study published in the journal Gut, in which researchers reported on […]

View full entry

Tags: Crohn's disease, Edward Loftus, Entyvio, GUT, IBD, monoclonal antibody, ulcerative colitis, Vedolizumab


April 19th, 2016

IBD or IBS – That is the Question

By Kanaaz Pereira kanaazpe

Many people are confused between two distinct gastrointestinal disorders: inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). Dr. Jean Fox, M.D., gives us a primer on the key differences, and similarities, between IBD and IBS. For more information about IBD and, visit mayoclinic.org/IBD. Dr. Fox is a gastroenterologist at Mayo Clinic.

View full entry

Tags: gastrointestinal disorders, IBD, IBS, Jean Fox


April 6th, 2016

Can You Teach a Teen New Tricks?

By Kanaaz Pereira kanaazpe

These days, everyone seems to have a coach. Here, Dr. Jeanne Tung, M.D., talks about problem solving coaching by telephone for teenagers with inflammatory bowel disease (IBD). We know that successfully taking medications for IBD is critical in inducing and maintaining remission. However, studies have shown that many teenagers may not be following through with […]

View full entry

Tags: coaching, IBD, Inflammatory Bowel Diseases, Jeanne Tung, medication adherence, phone counseling, teenagers


March 26th, 2016

Biologic Drugs – Are They Safe to Use During Pregnancy?

By Kanaaz Pereira kanaazpe

One of the major medical therapies used to treat chronic inflammatory conditions such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis are anti-tumor necrosis factor (anti-TNF) agents. These include, but are not limited to drugs like Remicade, Simponi, Humira and Cimzia. Women who are pregnant, and taking these medications are always concerned about […]

View full entry

Tags: Anti-TNF agents, Cimzia, Clinical Gastroenterology and Hepatology, Crohn's disease, Humira, IBD, pregnancy, psoriasis, Remicade, rheumatoid arthritis, Simponi, Sunanda Kane


March 24th, 2016

The New Birth Trend That’s All About Bacteria

By Kanaaz Pereira kanaazpe

It may sound strange, but some women who give birth by caesarean section (C-section) are covering their newborn in fluid swabbed from their vagina! A baby born vaginally is exposed to a plethora of different bacteria as it comes down the birth canal; these bacteria set up the child’s microbiome, (bacteria in human skin, guts, and […]

View full entry

Tags: bacteria, C-section, cesarean section, IBD, immune system, microbiome, Nature Medicine, Sunanda Kane


March 5th, 2016

Lifestyle and Diet in Inflammatory Bowel Disease

By Kanaaz Pereira kanaazpe

Note: This post was originally published on Mayo Clinic News Network  Inflammatory bowel disease (IBD), which consists of Crohn’s disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there is no clear evidence that one trigger alone causes problems. Therefore, there is no particular food, diet or lifestyle that causes, prevents […]

View full entry

Tags: Crohn's disease, diet, IBD, Mayo Clinic Health System, Sebastian Strobel, ulcerative colitis


Contact Us · Privacy Policy